Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial.
van Ruiten CC, van der Aart-van der Beek AB, IJzerman RG, Nieuwdorp M, Hoogenberg K, van Raalte DH, Heerspink HJL. van Ruiten CC, et al. Among authors: ijzerman rg. Diabetes Obes Metab. 2021 Aug;23(8):1851-1858. doi: 10.1111/dom.14410. Epub 2021 May 14. Diabetes Obes Metab. 2021. PMID: 33908691 Free PMC article. Clinical Trial.
Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial.
Schram MT, van Ittersum FJ, Spoelstra-de Man A, van Dijk RA, Schalkwijk CG, Ijzerman RG, Twisk JW, Stehouwer CD. Schram MT, et al. Among authors: ijzerman rg. J Hum Hypertens. 2005 Jun;19(6):429-37. doi: 10.1038/sj.jhh.1001812. J Hum Hypertens. 2005. PMID: 15647778 Clinical Trial.
Glucocorticoid treatment impairs microvascular function in healthy men in association with its adverse effects on glucose metabolism and blood pressure: a randomised controlled trial.
van Raalte DH, Diamant M, Ouwens DM, Ijzerman RG, Linssen MM, Guigas B, Eringa EC, Serné EH. van Raalte DH, et al. Among authors: ijzerman rg. Diabetologia. 2013 Nov;56(11):2383-91. doi: 10.1007/s00125-013-3016-8. Epub 2013 Aug 11. Diabetologia. 2013. PMID: 23933953 Clinical Trial.
Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans.
van Bloemendaal L, Veltman DJ, Ten Kulve JS, Groot PF, Ruhé HG, Barkhof F, Sloan JH, Diamant M, Ijzerman RG. van Bloemendaal L, et al. Among authors: ijzerman rg. Diabetes Obes Metab. 2015 Sep;17(9):878-86. doi: 10.1111/dom.12506. Epub 2015 Jul 22. Diabetes Obes Metab. 2015. PMID: 26094857 Clinical Trial.
Potential of butyrate to influence food intake in mice and men.
Fluitman KS, Wijdeveld M, Nieuwdorp M, IJzerman RG. Fluitman KS, et al. Among authors: ijzerman rg. Gut. 2018 Jul;67(7):1203-1204. doi: 10.1136/gutjnl-2017-315543. Epub 2018 Jan 30. Gut. 2018. PMID: 29382775 Free PMC article. No abstract available.
105 results